Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Menopause. 2013 Jul;20(7):777–784. doi: 10.1097/GME.0b013e31827ce57a

FIG. 5.

FIG. 5

Effects of BZA given alone and in combination with CEE on ERα expression and markers of ERα activity in the postmenopausal macaque endometrium (A-D). BZA treatment with and without CEE decreased ERα immunolabeling in the superficial and basal endometrium (A and B) compared to control and CEE alone (P < 0.0001 to P < 0.05 for all). The concomitant use of BZA and CEE significantly attenuated ERα-mediated expression of TFF1 and PGR (C and D) compared to CEE alone (P < 0.001 for all). n = 23, 24, 24, and 27 for control (CTL), BZA, CEE, and BZA+CEE co-therapy, respectively, for all measures. Treatment groups not connected by the same letter are significantly different. Values represent means ± 95% CI.